Reference Library

What is the Reference Library?

Keeping current with the retina literature is, for most, an ongoing, futile effort. New journals are constantly being introduced, and existing journals keep getting thicker and thicker. Researching a topic on PubMed doesn’t allow you to spot key references or quickly digest what’s new globally on a topic of interest. And remembering what you’ve read a few weeks later (or even after you’ve turned the page to the next article) is a struggle.

To address these concerns, we pull key clinical references from 24 major ophthalmic and retinal journals each month (click here for the journal list). Although we can’t provide the journal article PDF due to copyright issues, we provide a single-line citation with a brief summary of the article’s main points. Our goal is to capture all major clinically relevant references.

Please contact us if we’re missing any key references or if any reference is mis-summarized or cited.

Want to Automatically Receive Our Monthly Journal Article Summaries?

That’s easy! Just subscribe to the Retina World Congress’s monthly email blast here.

How is the Reference Library integrated into the Image Library?

At the top of most Image Library folders is a ___References Word document containing the annotated bibliography for that topic. Every month, we file key articles into the appropriate Retina Rocks folder(s) and update this file. Key articles are located at the top of the list. This allows for a rapid snapshot and review of the literature while also looking through our multimedia images. Some seemingly unrelated references are included in each folder to aid in differential diagnosis or to learn about similar findings in other disorders.

Key Retina Journal Articles of the Month

Here is the current month's snapshot of key retina journal articles

Monthly Archives

Predictive factors for injection interval extension after switching to faricimab in neovascular AMD: The FAR WEST multicentre study

Posnic A, Yagoub S, Lebastard C, Vaast M, Poinas A, Pabic EL, Bellamy JP, Delhay C, Faure S, Rouic JL, Henry A, Lebreton O, Masse H, Susini F, Guillaumie T, Fournier I, Mainguy A, Lez ML, Khanna RK, Mortemousque G, George A, Pipelart V, Bernard Y, Grimbert P, Mazhar D, Benzerroug M, Briend B, Clement M, Jammes-Veaux HP, Posnic MP, Bonissent A, Guyot C, Rousseau N, Dam BTV, Bellot L, Ferron R, Meur GL, Mouriaux F, Weber M, Maucourant Y, Ducloyer JB.

Acta Ophthalmol. 2026 Sep;104(6):e662-e670. doi: 10.1111/aos.70134.

nAMD Switching to Vabysmo after prior anti-VEGF for at least 1 year extended the recurrence-free interval — FAR WEST Retrospective, 845 eyes.

Clinical predictors of disease severity in nasal versus temporal retinopathy of prematurity

Nudelman NT, Ibrahim Z, Scallon S, Bheemireddy S, Feustel PJ, Salandy J, Storey NA, Barry GP.

Can J Ophthalmol. 2026 Aug;61(4):978-981. doi: 10.1016/j.jcjo.2026.02.008.

Eyes with nasal ROP (vs temporal-only disease) at initial presentation are more likely to require treatment — Retrospective, 542 eyes.

Interpreting Hyperreflective Foci in Age-Related Macular Degeneration: A Critical Review of Cell Origins, Evolving Terminology and Clinical Utility

Desmond T, Mehta H, Sehu W, Cherepanoff S.

Clin Exp Ophthalmol. 2026 Aug;54(6):796-811. doi: 10.1111/ceo.70128.

AMD hyperreflective foci are likely pigment-containing immune cells or possibly migrating RPE — Review.

International validation of a staging system for ciliary body and choroidal melanomas using estimated tumour volume

Nahon-Estève S, Caujolle JP, Maschi C, Navaratnam J, Krohn J, Eide NA, Kiliç E, Brosens E, Bassil FL, Rospond-Kubiak I, Krasińska-Płachta A, Sonntag SR, Tura A, Grisanti S, Stålhammar G.

Can J Ophthalmol. 2026 Aug;61(4):955-966. doi: 10.1016/j.jcjo.2026.01.020.

Uveal MM: New volume-based classification provides better prognostic discrimination than AJCC system — Retrospective, 5410 consecutive patients.

Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3

Liu T, Abreu-Arbaje NA, Andoh J, Arevalo JF, Avci R, Bach B, Bohorquez MC, Boldt HC, Boyce TM, Carauni AL, Carla MM, Chau VQ, Chou HD, Coche A, D’Alterio FM, Fan J, Felfeli T, Ferrara M, Ferreira MA, Goriup CG, Gotzaridis S, Gregori NZ, Habib AM, Han IC, Hsieh YT, Inoue M, Kadonosono K, Kamei M, Karabas LV, Keeley J, Kitahata S, Kumar S, Lai CC, Liu B, Lu L, Mahgoub MM, Mandelcorn E, Mansour A, Mateo C, Matoba R, Morizane Y, Morozova C, Nawrocka ZA, Nawrocki J, Nehemy MB, Nuesi R, Okonkwo ON, Tokuc EO, Ozdek S, Zeydanli EO, Park JG, Parolini B, Patelli F, Raizada S, Rashingkar R, Reifschneider E, Rezende FA, Rizzo S, Romano MR, Russell SR, Sabti KA, Sandinha T, Sauer L, Savastano A, Shroff D, Sohn EH, Steel DH, Szurman P, Tabandeh H, Than J, Thangamathesvaran L, Tsuboi K, Tsui MC, Viana AR, Walsh H, Williams GA, Williamson TH, Xi C, Yang CM, Yildiz AM, Yokoi T, Yonekawa Y, Zampogianni A, Mahmoud TH.

Retina. 2026 Aug 1;46(8):1345-1362. doi: 10.1097/IAE.0000000000004871.

PPV for large high myopic macular holes: Closure rates lower than non-high myopic eyes but get closure with meaningful VA gains — Retrospective, global, 499 eyes.

Maculopathy in Paclitaxel Users: Nationwide Drug Use, Incidence, and Risk Factors

Hwang S, Kim J, Chung JE, Ahn SJ.

Ophthalmol Retina. 2026 Aug;10(8):844-851. doi: 10.1016/j.oret.2026.03.019.

Paclitaxel cumulative incidence for macular edema and cystic maculopathy in 1.4%. More common with older age, female sex, dyslipidemia, liver disease, and greater cumulative dose — Retrospective, US HIRA database.

Consensus statement for the diagnosis and management of optic neuritis

Phuljhele S, Saxena R, Bhatia R, Khurana D, Dewan T, Meena SK, Gandepalli L, Sachdeva V, Sukhija J, Singh D, Sinha A, Dhiman R, Selvakumar A, Kumar M, Warjri GB, Mulay A, Gandhi R, Srivastava MVP, Jayakumar N.

Indian J Ophthalmol. 2026 Aug 1;74(8):1115-1121. doi: 10.4103/IJO.IJO_1634_26.

Optic neuritis diagnosis and management, Indian Neuro-Ophthalmology Society consensus statement.

No Optic Pit Retinoschisis (NOPIR): A Risk Factor for Glaucoma

Fujimoto S, Kokame GT, Maeno T, Usui S, Maruyama K, Nishida K.

J Vitreoretin Dis. 2026 Mar 11:24741264261427832. doi: 10.1177/24741264261427832

No optic pit retinoschisis can have glaucoma at baseline, but more commonly develops thereafter. Consider glaucoma screening at baseline for NOPIR patients — Retrospective, 13 eyes.

Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis

Zhang C, Bhatnagar A, Ersan S, Smiddy WE, Flynn HW Jr, Williams BK Jr.

Retina. 2026 Aug 1;46(8):1388-1395. doi: 10.1097/IAE.0000000000004861.

Management of PDR within the first year of Dx from 2005 to 2024: Shifted from PRP monotherapy toward anti-VEGF (including combination and monotherapy) — Retrospective, TriNetX database.

High-Resolution OCT of Presumed Basal Laminar Deposit and Retinal Pigment Epithelium Abnormalities in Extensive Macular Atrophy with Pseudodrusen-Like Appearance

Quarta A, Romano F, Alhelaly M, Feo A, Abbasgholizadeh R, Chujo S, Nardi C, Trinco A, Forte P, Huang J, Soylu C, Corradetti G, Corvi F, Sarraf D, Staurenghi G, Sadda SR.

Ophthalmol Retina. 2026 Aug;10(8):820-832. doi: 10.1016/j.oret.2026.04.020.

EMAP High-resolution OCT of presumed basal laminar deposits and RPE abnormalities. Highly prevalent with distinct phenotypes — Retrospective, 25 patients.

Prevalence of Systemic Comorbidities and Ocular Complications in Patients With Bilateral Retinal Telangiectasia

Zhao CS, Do DV, Sanislo SR, Ludwig C, Rahimy E, Mruthyunjaya P, Wai KM.

J Vitreoretin Dis. 2026 Mar 2:24741264261423313. doi: 10.1177/24741264261423313.

Bilateral MacTel2 has high coexisting diabetes and obesity — Retrospective, TriNetX database.

Pediatric Macular Hole Outcomes with Surgical and Nonsurgical Management: An IRIS® Registry Study

Holden DC Jr, Sudiran TN, Persad LS, Rohowetz LJ, Mar J, Patel NA, Flynn HW Jr, Berrocal AM, Yannuzzi NA.

Ophthalmol Retina. 2026 Aug;10(8):801-812. doi: 10.1016/j.oret.2026.04.005.

Pediatric macular holes: PPV high visual and anatomic success. Many also spontaneously resolve without surgery. Recommend individualized approach — Retrospective, IRIS registry.

A New Technique Using Ultra-Widefield Camera for Improved Neovascularization Detection in Diabetic Retinopathy

Mihara N, Funatsu R, Sonoda S, Sakono T, Okamura K, Hirokawa M, Tanabe Y, Sakamoto T, Terasaki H.

Retina. 2026 Aug 1;46(8):1380-1387. doi: 10.1097/IAE.0000000000004857.

Optos UWF imaging: Enhancing standard RG images with filtering techniques improves sensitivity for detecting PDR and NV while maintaining specificity — Retrospective, 30 eyes.

Expert Opinion: Management of Intraocular Inflammation and Vasculitis After Intravitreal Pegcetacoplan for Geographic Atrophy

Albini TA, Yeh S, Regillo CD, Schwartz R, Ferrone PJ, Baumal CR, Wykoff CC.

Ophthalmic Surg Lasers Imaging Retina. 2026 Aug;57(8):492-498. doi: 10.3928/23258160-20260521-03.

Post-Syfovre IOI + vasculitis 24 eyes (22 patients, 306,000 injections between 3-1-23 and 8-31-24). Median 10 days post-injection. 88% after 1st injection — Retrospective, Apellis, All reported cases.

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes

Samayamanthula S, Williams J, Markowski A, Nguyen C, Wan C, Mallepally A, Yates PA, Cusick M.

JAMA Ophthalmol. 2026 Aug 1;144(8):705-711. doi: 10.1001/jamaophthalmol.2026.2245.

In ophthalmology clinics, uncontrolled or previously unrecognized HTN highly prevalent (even for those engaged in routine medical FU) — Prospective, 172 patients.

Comparison of clinical profiles of idiopathic intracranial hypertension in patients with and without anemia

Balraj A, Rathinavel M, Sundaram S, Gokulvasanth D, Wagh A, Anand HB.

Indian J Ophthalmol. 2026 Aug 1;74(8):1169-1173. doi: 10.4103/IJO.IJO_2643_25.

Idiopathic intracranial HTN: Anemia and obesity are distinct triggers, BUT both groups have comparable structural and functional profiles — Prospective, 92 patients.

Clinical characteristics and outcomes of intraocular inflammation following intravitreal faricimab for neovascular age-related macular degeneration: a single-centre retrospective study

Al-Janabi A, Gallagher K, Stewart C, Williams G.

Eye (Lond). 2026 Aug;40(12):1929-1934. doi: 10.1038/s41433-026-04612-z.

Post-Vabysmo nAMD IOI in 0.13% of injections (14 eyes, 10805 injections). Mostly anterior and steroid-responsive with good final VA.

Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4

Feenstra HMA, El Mansori I, van Rijssen TJ, Tsonaka R, Diederen RMH, Hoyng CB, Schlingemann RO, Boon CJF, van Dijk EHC.

Acta Ophthalmol. 2026 Aug;104(5):e565-e577. doi: 10.1111/aos.70106.

ICSC Eplerenone vs PDT: Confirms PDT efficacy; 90% of initial eplerenone eyes failed at 3 months, but then 88% responded to PDT — SPECTRA RCT, 107 patients.

Sensitivity of ultra-widefield fundus photography for retinal break localisation in primary rhegmatogenous retinal detachment

Chou HC, Su YH, Lu JY, Altamirano F, Patel NA, Huang YT, Chen SN.

Eye (Lond). 2026 Aug;40(12):1914-1919. doi: 10.1038/s41433-026-04608-9.

UWF photos have limited sensitivity for detecting retinal breaks in preop RRD. Complements but doesn’t replace scleral depressed exam.

Centenarian Patients with Neovascular Age-Related Macular Degeneration

Capuano V, Fragiotta S, Abadou J, Sacconi R, Miere A, Amoroso F, Souied EH, Querques G.

Retina. 2026 Aug 1;46(8):1415-1423. doi: 10.1097/IAE.0000000000004837.

Centenarians with nAMD can maintain VA with long-term anti-VEGF therapy —Retrospective, 28 eyes (14 patients).

Incidence and Risk Factors of Full-Thickness Macular Hole in Fellow Eyes

Canizares L, Abdelmassih Y, Chapron T, Chehaibou I, Le Mer Y, Bruneau S, Metge F, Couturier A, Caputo G.

Ophthalmol Retina. 2026 Aug;10(8):792-800. doi: 10.1016/j.oret.2026.04.004.

Fellow eye develops macular hole in 12% at 5 years. Main risks are VMT and no PVD — Retrospective, 576 patients.

Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology

DeParis SW, Oke I, Gaier ED, Moss HE, MacIntosh PW, Gilbert AL, Dinkin MJ, Chen JJ.

Ophthalmology. 2026 Aug;133(8):1029-1035. doi: 10.1016/j.ophtha.2026.04.008.

NAION and GLP1 agonists: small but possible increased risk, which remains low. Consensus statement by the North American Neuro-Ophthalmology Society and American Academy of Ophthalmology.